Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Bio-Pharmaceutical Industry Technology Institute is a specialized research and development organization based in Wuhan, China, serving as the primary innovation hub for Humanwell Healthcare. Established in 2012, the institute focuses on the discovery and industrialization of innovative small molecules, high-end generics, and complex drug delivery systems, particularly in the fields of anesthesia and analgesia. It operates as a collaborative platform that bridges academic research with industrial application, managing several state-level laboratories and pilot production facilities. The institute plays a central role in the Wuhan National Bio-industry Base (Biolake), providing comprehensive R&D services ranging from lead optimization to clinical trial management for its parent company and regional partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Bio Pharmaceutical Industry Technology Institute.